project . 2019 - 2019 . Closed

DELOX

Next generation decontamination: fast, effective, cheap and non-toxic
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 837148 Call for proposal: H2020-SMEInst-2018-2020-1
  • Funded under: H2020 | SME-1 Overall Budget: 71,429 EURFunder Contribution: 50,000 EUR
  • Status: Closed
  • Start Date
    01 Jan 2019
    End Date
    30 Jun 2019
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Hospital acquired infections affect 1 in every 14 patients, a number that goes as high as 1 in every 5 patients when considering intensive care units. Delox has the potential to change that. Decontamination is performed using several different methods and technologies nowadays. The most relevant one is sterilization, which is an expensive procedure, typically only affordable for very large hospital in well developed countries or outsourced to a specialized firm. In the laboratory and health context the use of Formaldehyde is also still frequent – because it is price competitive – but it is toxic and far from perfect. The state-of-the-art technology is VHP (Vapor...
Description
Hospital acquired infections affect 1 in every 14 patients, a number that goes as high as 1 in every 5 patients when considering intensive care units. Delox has the potential to change that. Decontamination is performed using several different methods and technologies nowadays. The most relevant one is sterilization, which is an expensive procedure, typically only affordable for very large hospital in well developed countries or outsourced to a specialized firm. In the laboratory and health context the use of Formaldehyde is also still frequent – because it is price competitive – but it is toxic and far from perfect. The state-of-the-art technology is VHP (Vapor...
Any information missing or wrong?Report an Issue